Clin2
NCT07460947Possibly a fitRecruiting

One-day TMS and medicine for suicidal thoughts in BPD

Borderline Personality Disorder (BPD)

Treatments studied

Part of Mental health clinical trials.

This trial tests if a single day of accelerated transcranial magnetic stimulation (TMS) combined with the medication D-cycloserine can reduce suicidal thoughts in people with borderline personality disorder (BPD). It aims to find a fast-acting treatment option for those who are struggling.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with borderline personality disorder (BPD).
  • You have had moderate to severe suicidal thoughts in the past two weeks.
  • You are not currently in a manic or hypomanic episode or experiencing serious psychotic symptoms.
  • You do not have a severe alcohol or drug problem that would interfere with treatment.
  • You have no metal in your head or neck, no history of seizures, and are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07714005Not yet recruiting
Brain stimulation and emotion skills training for borderline personality disorder

This study tests if combining a noninvasive brain stimulation technique (TMS) with emotion regulation skills training can help people with borderline personality disorder better manage their emotions. You must have significant emotional difficulties and be between 22 and 65 years old.

NCT06675461Enrolling by invitation
Brief talk therapy for suicidal patients with borderline personality disorder

This trial tests a short talk therapy for people with borderline personality disorder who come to the emergency department after hurting themselves or thinking about suicide. The goal is to see if this brief help can ease suicidal thoughts and keep you safer.

Toronto, Ontario
NCT07569198Recruiting· Phase 2
Ketamine plus therapy for depression with suicidal thoughts

This study tests whether ketamine (a medication) combined with a specific type of therapy called DBT can help people with treatment-resistant depression and borderline personality disorder who are having thoughts of suicide. You would receive ketamine infusions alongside structured therapy sessions over 6 months.

Toronto, Ontario
NCT06683014Recruiting· Phase 2
MDMA study for borderline personality disorder

This trial tests if a single dose of MDMA, given under supervision, can help people with borderline personality disorder (BPD). You will stay overnight after the session and be followed up for two weeks.

New Haven, Connecticut
NCT07560878Recruiting· Early Phase 1
Brain Stimulation and Medication Study for Depression

This early-stage study tests a type of magnetic brain stimulation called theta burst stimulation combined with study medications to help treat moderate to severe depression. Researchers want to understand how this combination affects brain communication and may help reduce depressive symptoms.

Belmont, Massachusetts
NCT07593222Not yet recruiting· Phase 1/Phase 2
Brain Stimulation and Medication Study for Depression

This study tests a type of brain stimulation called theta burst stimulation combined with study medications to see if it can help treat major depression. Researchers want to understand how this treatment works in the brain and whether it might be more effective than current treatments.

Belmont, Massachusetts

Hear when a new Borderline Personality Disorder (BPD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.